(Q38085966)

28 August 2017

title

Transforming growth factor β family members in regulation of vascular function: in the light of vascular conditional knockouts (English)

1 reference

28 August 2017

1

Lars Jakobsson

1 reference

28 August 2017

author name string

Laurens A van Meeteren

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

27 February 2013

1 reference

Experimental Cell Research

28 August 2017

published in

1 reference

28 August 2017

volume

319

1 reference

28 August 2017

issue

9

1 reference

28 August 2017

page(s)

1264-1270

1 reference

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Extracellular control of TGFbeta signalling in vascular development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Expression cloning and characterization of the TGF-beta type III receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

The regulation of TGFbeta signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Non-Smad TGF-beta signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Endothelial/pericyte interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Pericytes: developmental, physiological, and pathological perspectives, problems, and promises

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Transforming growth factor-betas and vascular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Regulation of differentiation of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Signaling via the Tgf-beta type I receptor Alk5 in heart development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Tgfbeta signaling is required for atrioventricular cushion mesenchyme remodeling during in vivo cardiac development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

TGF-β signaling in endothelial cells, but not neuroepithelial cells, is essential for cerebral vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

The TGFβ type II receptor plays a critical role in the endothelial cells during cardiac development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Endothelial expression of TGFβ type II receptor is required to maintain vascular integrity during postnatal development of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Defective retinal vascular endothelial cell development as a consequence of impaired integrin αVβ8-mediated activation of transforming growth factor-β.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

VE-cadherin is a critical endothelial regulator of TGF-beta signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Conditional inactivation of TGF-β type II receptor in smooth muscle cells and epicardium causes lethal aortic and cardiac defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Inactivation of Smad5 in endothelial cells and smooth muscle cells demonstrates that Smad5 is required for cardiac homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

SMAD4 mutations found in unselected HHT patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

Targeting the TGFβ signalling pathway in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.015

10.1016/J.YEXCR.2013.02.015

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference